Strides Pharma Science Ltd - 532531 - Intimation Pursuant To Regulation 31A Of Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation pursuant to Regulation 31A of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 13, 2023 for Pronomz Ventures LLP Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides flagship facility in Bangalore receives USFDA inspection closure Strides Pharma Science Ltd - 532531 - Intimation Pursuant To Regulation 31A Of Sebl (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the above, we wish to inform you that both the Stock Exchanges i.e., BSE Limited (BSE) and the National Stock Exchange of India Limited (NSE) have approved the reclassification of Outgoing Promoters 1 from 'Promoter/ Promoter Group' to 'Public' shareholding Category on February 22, 2023. Copy of approval letter received from BSE and NSE is enclosed for your reference. Consequent to the said reclassification, promoter shareholding in the Company as at date shall be 27.97% (as against 31.04% prior to the said reclassification). Request you to kindly take the same on record and oblige. Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our intimation letter dated February 20, 2023 and in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copies of newspaper advertisement regarding completion of dispatch of Notice of Postal Ballot dated January 24, 2023. Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In line with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, enclosed herewith is the Notice of Postal Ballot dated January 24, 2023. Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on February 20, 2023 for Karuna Business Solutions LLP Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Sushila Chudiwala Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on February 15, 2023 for Pronomz Ventures LLP Strides Pharma Science Ltd - 532531 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on February 10, 2023 for Pronomz Ventures LLP